United States Therapeutic Vaccines Market Report 2017

November 2017 | 104 pages | ID: UC270D578CBWEN
QYResearch

Abstracts

In this report, the United States Therapeutic Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Therapeutic Vaccines in these regions, from 2012 to 2022 (forecast).

United States Therapeutic Vaccines market competition by top manufacturers/players, with Therapeutic Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Northeast Biotherapeutics
• Agenus
• Vaccinogen Inc
• CIMAB S.A
• Dendreon
• Corixa
• AVAX

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Peptide Therapeutic Vaccine
• Cell Therapeutic Vaccine
• Nucleic Acid Therapeutic Vaccine

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Therapeutic Vaccines for each application, including

• Oncotherapy
• Hepatitis B
• Tuberculosis
• Herpes Simplex Virus
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Therapeutic Vaccines Market Report 2017

1 THERAPEUTIC VACCINES OVERVIEW

1.1 Product Overview and Scope of Therapeutic Vaccines
1.2 Classification of Therapeutic Vaccines by Product Category
  1.2.1 United States Therapeutic Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Therapeutic Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Peptide Therapeutic Vaccine
  1.2.4 Cell Therapeutic Vaccine
  1.2.5 Nucleic Acid Therapeutic Vaccine
1.3 United States Therapeutic Vaccines Market by Application/End Users
  1.3.1 United States Therapeutic Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Oncotherapy
  1.3.3 Hepatitis B
  1.3.4 Tuberculosis
  1.3.5 Herpes Simplex Virus
  1.3.6 Others
1.4 United States Therapeutic Vaccines Market by Region
  1.4.1 United States Therapeutic Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Therapeutic Vaccines Status and Prospect (2012-2022)
  1.4.3 Southwest Therapeutic Vaccines Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Therapeutic Vaccines Status and Prospect (2012-2022)
  1.4.5 New England Therapeutic Vaccines Status and Prospect (2012-2022)
  1.4.6 The South Therapeutic Vaccines Status and Prospect (2012-2022)
  1.4.7 The Midwest Therapeutic Vaccines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Therapeutic Vaccines (2012-2022)
  1.5.1 United States Therapeutic Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 United States Therapeutic Vaccines Revenue and Growth Rate (2012-2022)

2 UNITED STATES THERAPEUTIC VACCINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Therapeutic Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Therapeutic Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Therapeutic Vaccines Average Price by Players/Suppliers (2012-2017)
2.4 United States Therapeutic Vaccines Market Competitive Situation and Trends
  2.4.1 United States Therapeutic Vaccines Market Concentration Rate
  2.4.2 United States Therapeutic Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Therapeutic Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES THERAPEUTIC VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Therapeutic Vaccines Sales and Market Share by Region (2012-2017)
3.2 United States Therapeutic Vaccines Revenue and Market Share by Region (2012-2017)
3.3 United States Therapeutic Vaccines Price by Region (2012-2017)

4 UNITED STATES THERAPEUTIC VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Therapeutic Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Therapeutic Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Therapeutic Vaccines Price by Type (2012-2017)
4.4 United States Therapeutic Vaccines Sales Growth Rate by Type (2012-2017)

5 UNITED STATES THERAPEUTIC VACCINES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Therapeutic Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States Therapeutic Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES THERAPEUTIC VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Northeast Biotherapeutics
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Therapeutic Vaccines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Agenus
  6.2.2 Therapeutic Vaccines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Agenus Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Vaccinogen Inc
  6.3.2 Therapeutic Vaccines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 CIMAB S.A
  6.4.2 Therapeutic Vaccines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Dendreon
  6.5.2 Therapeutic Vaccines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Dendreon Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Corixa
  6.6.2 Therapeutic Vaccines Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Corixa Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 AVAX
  6.7.2 Therapeutic Vaccines Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 AVAX Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 THERAPEUTIC VACCINES MANUFACTURING COST ANALYSIS

7.1 Therapeutic Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Therapeutic Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Therapeutic Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Therapeutic Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES THERAPEUTIC VACCINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Therapeutic Vaccines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Therapeutic Vaccines Sales Volume Forecast by Type (2017-2022)
11.3 United States Therapeutic Vaccines Sales Volume Forecast by Application (2017-2022)
11.4 United States Therapeutic Vaccines Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Therapeutic Vaccines
Figure United States Therapeutic Vaccines Market Size (K Pcs) by Type (2012-2022)
Figure United States Therapeutic Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Peptide Therapeutic Vaccine Product Picture
Figure Cell Therapeutic Vaccine Product Picture
Figure Nucleic Acid Therapeutic Vaccine Product Picture
Figure United States Therapeutic Vaccines Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Therapeutic Vaccines by Application in 2016
Figure Oncotherapy Examples
Table Key Downstream Customer in Oncotherapy
Figure Hepatitis B Examples
Table Key Downstream Customer in Hepatitis B
Figure Tuberculosis Examples
Table Key Downstream Customer in Tuberculosis
Figure Herpes Simplex Virus Examples
Table Key Downstream Customer in Herpes Simplex Virus
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Therapeutic Vaccines Market Size (Million USD) by Region (2012-2022)
Figure The West Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Therapeutic Vaccines Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Therapeutic Vaccines Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Therapeutic Vaccines Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Therapeutic Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Therapeutic Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Therapeutic Vaccines Sales Share by Players/Suppliers
Figure United States Therapeutic Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Therapeutic Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Therapeutic Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Therapeutic Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Therapeutic Vaccines Revenue Share by Players/Suppliers
Table United States Market Therapeutic Vaccines Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Therapeutic Vaccines Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Therapeutic Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Therapeutic Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Therapeutic Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Therapeutic Vaccines Product Category
Table United States Therapeutic Vaccines Sales (K Pcs) by Region (2012-2017)
Table United States Therapeutic Vaccines Sales Share by Region (2012-2017)
Figure United States Therapeutic Vaccines Sales Share by Region (2012-2017)
Figure United States Therapeutic Vaccines Sales Market Share by Region in 2016
Table United States Therapeutic Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Therapeutic Vaccines Revenue Share by Region (2012-2017)
Figure United States Therapeutic Vaccines Revenue Market Share by Region (2012-2017)
Figure United States Therapeutic Vaccines Revenue Market Share by Region in 2016
Table United States Therapeutic Vaccines Price (USD/Pcs) by Region (2012-2017)
Table United States Therapeutic Vaccines Sales (K Pcs) by Type (2012-2017)
Table United States Therapeutic Vaccines Sales Share by Type (2012-2017)
Figure United States Therapeutic Vaccines Sales Share by Type (2012-2017)
Figure United States Therapeutic Vaccines Sales Market Share by Type in 2016
Table United States Therapeutic Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Therapeutic Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Therapeutic Vaccines by Type (2012-2017)
Figure Revenue Market Share of Therapeutic Vaccines by Type in 2016
Table United States Therapeutic Vaccines Price (USD/Pcs) by Types (2012-2017)
Figure United States Therapeutic Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Therapeutic Vaccines Sales (K Pcs) by Application (2012-2017)
Table United States Therapeutic Vaccines Sales Market Share by Application (2012-2017)
Figure United States Therapeutic Vaccines Sales Market Share by Application (2012-2017)
Figure United States Therapeutic Vaccines Sales Market Share by Application in 2016
Table United States Therapeutic Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Therapeutic Vaccines Sales Growth Rate by Application (2012-2017)
Table Northeast Biotherapeutics Basic Information List
Table Northeast Biotherapeutics Therapeutic Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Northeast Biotherapeutics Therapeutic Vaccines Sales Growth Rate (2012-2017)
Figure Northeast Biotherapeutics Therapeutic Vaccines Sales Market Share in United States (2012-2017)
Figure Northeast Biotherapeutics Therapeutic Vaccines Revenue Market Share in United States (2012-2017)
Table Agenus Basic Information List
Table Agenus Therapeutic Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Agenus Therapeutic Vaccines Sales Growth Rate (2012-2017)
Figure Agenus Therapeutic Vaccines Sales Market Share in United States (2012-2017)
Figure Agenus Therapeutic Vaccines Revenue Market Share in United States (2012-2017)
Table Vaccinogen Inc Basic Information List
Table Vaccinogen Inc Therapeutic Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Vaccinogen Inc Therapeutic Vaccines Sales Growth Rate (2012-2017)
Figure Vaccinogen Inc Therapeutic Vaccines Sales Market Share in United States (2012-2017)
Figure Vaccinogen Inc Therapeutic Vaccines Revenue Market Share in United States (2012-2017)
Table CIMAB S.A Basic Information List
Table CIMAB S.A Therapeutic Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CIMAB S.A Therapeutic Vaccines Sales Growth Rate (2012-2017)
Figure CIMAB S.A Therapeutic Vaccines Sales Market Share in United States (2012-2017)
Figure CIMAB S.A Therapeutic Vaccines Revenue Market Share in United States (2012-2017)
Table Dendreon Basic Information List
Table Dendreon Therapeutic Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dendreon Therapeutic Vaccines Sales Growth Rate (2012-2017)
Figure Dendreon Therapeutic Vaccines Sales Market Share in United States (2012-2017)
Figure Dendreon Therapeutic Vaccines Revenue Market Share in United States (2012-2017)
Table Corixa Basic Information List
Table Corixa Therapeutic Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Corixa Therapeutic Vaccines Sales Growth Rate (2012-2017)
Figure Corixa Therapeutic Vaccines Sales Market Share in United States (2012-2017)
Figure Corixa Therapeutic Vaccines Revenue Market Share in United States (2012-2017)
Table AVAX Basic Information List
Table AVAX Therapeutic Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AVAX Therapeutic Vaccines Sales Growth Rate (2012-2017)
Figure AVAX Therapeutic Vaccines Sales Market Share in United States (2012-2017)
Figure AVAX Therapeutic Vaccines Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Therapeutic Vaccines
Figure Manufacturing Process Analysis of Therapeutic Vaccines
Figure Therapeutic Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Therapeutic Vaccines Major Players/Suppliers in 2016
Table Major Buyers of Therapeutic Vaccines
Table Distributors/Traders List
Figure United States Therapeutic Vaccines Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Therapeutic Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Therapeutic Vaccines Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Therapeutic Vaccines Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Therapeutic Vaccines Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Therapeutic Vaccines Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Therapeutic Vaccines Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Therapeutic Vaccines Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Therapeutic Vaccines Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Therapeutic Vaccines Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Therapeutic Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Therapeutic Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Therapeutic Vaccines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources